{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:03:33Z","timestamp":1794546213403,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24wm0625120"],"award-info":[{"award-number":["JP24wm0625120"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0425019"],"award-info":[{"award-number":["JP21wm0425019"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24dk0207074h0001"],"award-info":[{"award-number":["JP24dk0207074h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K16482"],"award-info":[{"award-number":["JP20K16482"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K21773"],"award-info":[{"award-number":["JP25K21773"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24H00624"],"award-info":[{"award-number":["JP24H00624"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJCR18H3"],"award-info":[{"award-number":["JPMJCR18H3"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>TDP-43 proteinopathies, such as frontotemporal degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), are classified into five neuropathological subtypes, Types A to E, according to the morphology of TDP-43 inclusions. Recent cryo-electron microscopy analysis of FTLD-TDP cases demonstrated that TDP-43 filaments composing the inclusions are structurally different depending on the subtype, and remarkably, co-assembled heteromeric filaments of TDP-43 and annexin A11 (ANXA11) were identified in Type C. Therefore, the involvement of ANXA11 in TDP-43 proteinopathy should be further examined. Here, we pathologically and biochemically analyzed four cases of primary lateral sclerosis-phenotype FTLD\/motor neuron disease (MND) with TDP-43 pathology (PLS-TDP), and found that ANXA11 co-localizes with FTLD-TDP Type A pathology in PLS-TDP. Immunoblot analysis of the PLS-TDP cases revealed that the banding patterns of C-terminal and chymotrypsin-resistant fragments of TDP-43 are distinct from those of FTLD-TDP Types A, B and C. In addition, the N-terminal fragments of ANXA11 appear to be different from those of FTLD-TDP Type C. Filaments extracted from PLS-TDP cases were TDP-43- and ANXA11-immunopositive, suggesting the presence of TDP-ANXA11 heteromeric filaments. These results suggest that co-aggregation of ANXA11 and TDP-43 may serve as a neuropathological and biochemical indicator distinguishing PLS from ALS in FTLD\/MND.<\/jats:p>","DOI":"10.1186\/s40478-025-02210-w","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T12:45:37Z","timestamp":1767530737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Co-aggregation of annexin A11 and TDP-43 in FTLD\/MND with primary lateral sclerosis phenotype"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-9070","authenticated-orcid":false,"given":"Airi","family":"Tarutani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0830-9403","authenticated-orcid":false,"given":"Takashi","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M. A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-8159","authenticated-orcid":false,"given":"Masato","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"key":"2210_CR1","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1212\/01.wnl.0000277270.99272.7e","volume":"69","author":"KA Josephs","year":"2007","unstructured":"Josephs KA, Dickson DW (2007) Frontotemporal lobar degeneration with upper motor neuron disease\/ primary lateral sclerosis. Neurology 69:1800\u20131801. https:\/\/doi.org\/10.1212\/01.wnl.0000277270.99272.7e","journal-title":"Neurology"},{"issue":"Pt 2","key":"2210_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/brain\/115.2.495","volume":"115","author":"CE Pringle","year":"1992","unstructured":"Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC (1992) Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 115(Pt 2):495\u2013520. https:\/\/doi.org\/10.1093\/brain\/115.2.495","journal-title":"Brain"},{"key":"2210_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-003-0687-0","volume":"105","author":"CF Tan","year":"2003","unstructured":"Tan CF, Kakita A, Piao YS, Kikugawa K, Endo K, Tanaka M, Okamoto K, Takahashi H (2003) Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathol 105:615\u2013620. https:\/\/doi.org\/10.1007\/s00401-003-0687-0","journal-title":"Acta Neuropathol"},{"key":"2210_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/21678421.2017.1354996","volume":"18","author":"BS de Vries","year":"2017","unstructured":"de Vries BS, Rustemeijer LMM, van der Kooi AJ, Raaphorst J, Schroder CD, Nijboer TCW, Hendrikse J, Veldink JH, van den Berg LH, van Es MA (2017) A case series of PLS patients with frontotemporal dementia and overview of the literature. Amyotroph Lateral Scler Frontotemporal Degener 18:534\u2013548. https:\/\/doi.org\/10.1080\/21678421.2017.1354996","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2210_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/21678421.2020.1790607","volume":"21","author":"IRA Mackenzie","year":"2020","unstructured":"Mackenzie IRA, Briemberg H (2020) TDP-43 pathology in primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 21:52\u201358. https:\/\/doi.org\/10.1080\/21678421.2020.1790607","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2210_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","volume":"12","author":"EL Scotter","year":"2015","unstructured":"Scotter EL, Chen HJ, Shaw CE (2015) TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics 12:352\u2013363. https:\/\/doi.org\/10.1007\/s13311-015-0338-x","journal-title":"Neurotherapeutics"},{"key":"2210_CR7","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/brain\/124.10.1989","volume":"124","author":"N Le Forestier","year":"2001","unstructured":"Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, Pradat PF, Lacomblez L, Meininger V (2001) Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 124:1989\u20131999. https:\/\/doi.org\/10.1093\/brain\/124.10.1989","journal-title":"Brain"},{"key":"2210_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111\u2013113. https:\/\/doi.org\/10.1007\/s00401-011-0845-8","journal-title":"Acta Neuropathol"},{"key":"2210_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","volume":"134","author":"EB Lee","year":"2017","unstructured":"Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, Elman L, Grossman M, Lee VM, Irwin DJet (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65\u201378. https:\/\/doi.org\/10.1007\/s00401-017-1679-9","journal-title":"Acta Neuropathol"},{"key":"2210_CR10","doi-asserted-by":"publisher","unstructured":"Arseni D, Chen R, Murzin AG, Peak-Chew SY, Garringer HJ, Newell KL, Kametani F, Robinson AC, Vidal R, Ghetti B et al (2023) TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature 620: 898\u2013903 https:\/\/doi.org\/10.1038\/s41586-023-06405-w","DOI":"10.1038\/s41586-023-06405-w"},{"key":"2210_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-021-04199-3","volume":"601","author":"D Arseni","year":"2022","unstructured":"Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M, Ryskeldi-Falcon B (2022) Structure of pathological TDP-43 filaments from ALS with FTLD. Nature 601:139\u2013143. https:\/\/doi.org\/10.1038\/s41586-021-04199-3","journal-title":"Nature"},{"key":"2210_CR12","doi-asserted-by":"publisher","unstructured":"Arseni D, Nonaka T, Jacobsen MH, Murzin AG, Cracco L, Peak-Chew SY, Garringer HJ, Kawakami I, Suzuki H, Onaya M et al (2024) Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C. Nature 634: 662\u2013668 https:\/\/doi.org\/10.1038\/s41586-024-08024-5","DOI":"10.1038\/s41586-024-08024-5"},{"key":"2210_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita Met (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60\u201370. https:\/\/doi.org\/10.1002\/ana.21425","journal-title":"Ann Neurol"},{"key":"2210_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-022-02426-3","volume":"143","author":"A Tarutani","year":"2022","unstructured":"Tarutani A, Adachi T, Akatsu H, Hashizume Y, Hasegawa K, Saito Y, Robinson AC, Mann DMA, Yoshida M, Murayama Set (2022) Ultrastructural and biochemical classification of pathogenic tau, alpha-synuclein and TDP-43. Acta Neuropathol 143:613\u2013640. https:\/\/doi.org\/10.1007\/s00401-022-02426-3","journal-title":"Acta Neuropathol"},{"key":"2210_CR15","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/aws230","volume":"135","author":"H Tsuji","year":"2012","unstructured":"Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, Hosokawa M, Yoshida M, Hatsuta H, Takao Met al et al (2012) Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135:3380\u20133391. https:\/\/doi.org\/10.1093\/brain\/aws230","journal-title":"Brain"},{"key":"2210_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1440-1789.2011.01271.x","volume":"32","author":"T Kosaka","year":"2012","unstructured":"Kosaka T, Fu YJ, Shiga A, Ishidaira H, Tan CF, Tani T, Koike R, Onodera O, Nishizawa M, Kakita Aet (2012) Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration\u2013immunohistochemical and biochemical analyses of TDP-43. Neuropathology 32:373\u2013384. https:\/\/doi.org\/10.1111\/j.1440-1789.2011.01271.x","journal-title":"Neuropathology"},{"key":"2210_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/21678421.2020.1837173","volume":"21","author":"IRA Mackenzie","year":"2020","unstructured":"Mackenzie IRA (2020) Neuropathology of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 21:47\u201351. https:\/\/doi.org\/10.1080\/21678421.2020.1837173","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2210_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00401-024-02753-7","volume":"147","author":"JL Robinson","year":"2024","unstructured":"Robinson JL, Suh E, Xu Y, Hurtig HI, Elman L, McMillan CT, Irwin DJ, Porta S, Van Deerlin VM, Lee EB (2024) Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies. Acta Neuropathol 147:104. https:\/\/doi.org\/10.1007\/s00401-024-02753-7","journal-title":"Acta Neuropathol"},{"key":"2210_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-003-0818-7","volume":"107","author":"A Mochizuki","year":"2004","unstructured":"Mochizuki A, Komatsuzaki Y, Iwamoto H, Shoji S (2004) Frontotemporal dementia with ubiquitinated neuronal inclusions presenting with primary lateral sclerosis and parkinsonism: clinicopathological report of an autopsy case. Acta Neuropathol 107:377\u2013380. https:\/\/doi.org\/10.1007\/s00401-003-0818-7","journal-title":"Acta Neuropathol"},{"key":"2210_CR20","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/brain\/awab091","volume":"144","author":"A Tarutani","year":"2021","unstructured":"Tarutani A, Miyata H, Nonaka T, Hasegawa K, Yoshida M, Saito Y, Murayama S, Robinson AC, Mann DMA, Tomita Tet al et al (2021) Human tauopathy-derived Tau strains determine the substrates recruited for templated amplification. Brain 144:2333\u20132348. https:\/\/doi.org\/10.1093\/brain\/awab091","journal-title":"Brain"},{"key":"2210_CR21","doi-asserted-by":"publisher","unstructured":"Yamashita R, Beck G, Shigenobu K, Tarutani A, Yonenobu Y, Kawai M, Mori K, Tahara S, Satake Y, Saito Y et al (2025) Motor involvement in frontotemporal lobar degeneration with TAR DNA-binding protein of 43\u00a0kDa type C. Neuropathology: https:\/\/doi.org\/10.1111\/neup.13026","DOI":"10.1111\/neup.13026"},{"key":"2210_CR22","doi-asserted-by":"publisher","unstructured":"de Boer EMJ, de Vries BS, Van Hecke W, Muhlebner A, Vincken KL, Mol CP, van Rheenen W, Westeneng HJ, Veldink JH Hoglinger GU (2024) diagnosing primary lateral sclerosis: a clinico-pathological study. J Neurol 272: 46 https:\/\/doi.org\/10.1007\/s00415-024-12816-0","DOI":"10.1007\/s00415-024-12816-0"},{"key":"2210_CR23","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1007\/s00415-023-11746-7","volume":"270","author":"EMJ de Boer","year":"2023","unstructured":"de Boer EMJ, de Vries BS, Pennings M, Kamsteeg EJ, Veldink JH, van den Berg LH, van Es MA (2023) Genetic characterization of primary lateral sclerosis. J Neurol 270:3970\u20133980. https:\/\/doi.org\/10.1007\/s00415-023-11746-7","journal-title":"J Neurol"},{"key":"2210_CR24","doi-asserted-by":"publisher","unstructured":"Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, King A, Ticozzi N, Kenna KP, Soragia-Gkazi A et al (2017) Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci Transl Med 9: https:\/\/doi.org\/10.1126\/scitranslmed.aad9157","DOI":"10.1126\/scitranslmed.aad9157"},{"key":"2210_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad306","volume":"5","author":"M Audrain","year":"2023","unstructured":"Audrain M, Egesipe AL, Tentillier N, Font L, Ratnam M, Mottier L, Clavel M, Le Roux-Bourdieu M, Fenyi A, Ollier R, Chevalier E, Guilhot F, Fuchs A, Piorkowska K, Carlyle B, Arnold SE, Berry JD, Luthi-Carter R, Adolfsson O, Pfeifer A, Kosco-Vilbois M, Seredenina T, Afroz T (2023) Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF. Brain Commun 5:fcad306. https:\/\/doi.org\/10.1093\/braincomms\/fcad306","journal-title":"Brain Commun"},{"key":"2210_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","volume":"117","author":"T Kasai","year":"2009","unstructured":"Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, Mann DM, Allsop D, Nakagawa M (2009) Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol 117:55\u201362. https:\/\/doi.org\/10.1007\/s00401-008-0456-1","journal-title":"Acta Neuropathol"},{"key":"2210_CR27","doi-asserted-by":"publisher","unstructured":"Scialo C, Tran TH, Salzano G, Novi G, Caponnetto C, Chio A, Calvo A, Canosa A, Moda F, Caroppo P et al (2020) TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients. Brain Commun 2: fcaa142 https:\/\/doi.org\/10.1093\/braincomms\/fcaa142","DOI":"10.1093\/braincomms\/fcaa142"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02210-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02210-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02210-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:08:01Z","timestamp":1770120481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02210-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2210"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02210-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Autopsies were carried out after written informed consent was obtained from family members, and the study protocols were approved by the ethical committees of Tokyo Metropolitan Institute of Medical Science, Aichi Medical University, the University of Tsukuba and Niigata University. All methods were performed in accordance with the relevant guidelines and regulations. Cases supplied by Manchester Brain Bank were either considered exempt from consent under the UK Human Tissue Act 2004 (cases collected before 1\u2009st September 2006) or has written informed consent in place (cases collected after 1\u2009st September 2006). All brain tissues were anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}